Welcome!

News Feed Item

Tremor Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Tremor Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-2014.html

Tremor Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tremor Global Clinical Trials Review, H2, 2014" provides data on the Tremor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tremor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tremor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Tremor 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17

In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Tremor 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Tremor Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Top Institutes / Government 28
University of Alabama at Birmingham 28
Clinical Trial Overview of University of Alabama at Birmingham 28
National Institute of Neurological Disorders and Stroke 29
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 29
Boston Children's Hospital 30
Clinical Trial Overview of Boston Children's Hospital 30
Ohio State University 31

Clinical Trial Overview of Ohio State University 31
Emory University 32
Clinical Trial Overview of Emory University 32
Mayo Clinic 33
Clinical Trial Overview of Mayo Clinic 33
Syracuse University 34
Clinical Trial Overview of Syracuse University 34
Yazd Medical University 35
Clinical Trial Overview of Yazd Medical University 35
Mount Sinai Hospital 36
Clinical Trial Overview of Mount Sinai Hospital 36
University of California, Davis 37
Clinical Trial Overview of University of California, Davis 37
Five Key Clinical Profiles 38
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables
Tremor Therapeutics, Global, Clinical Trials by Region, 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Tremor Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Tremor Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Tremor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2014* 27
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 28
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 29
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 30

Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 31
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 32
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 33
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Syracuse University, 2014* 34
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yazd Medical University, 2014* 35
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014* 36
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 37

List of Figures
Tremor Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9

Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 60

Read the full report:
Tremor Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-

2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com  
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: imple...
High-velocity engineering teams are applying not only continuous delivery processes, but also lessons in experimentation from established leaders like Amazon, Netflix, and Facebook. These companies have made experimentation a foundation for their release processes, allowing them to try out major feature releases and redesigns within smaller groups before making them broadly available. In his session at 21st Cloud Expo, Brian Lucas, Senior Staff Engineer at Optimizely, will discuss how by using...
In this strange new world where more and more power is drawn from business technology, companies are effectively straddling two paths on the road to innovation and transformation into digital enterprises. The first path is the heritage trail – with “legacy” technology forming the background. Here, extant technologies are transformed by core IT teams to provide more API-driven approaches. Legacy systems can restrict companies that are transitioning into digital enterprises. To truly become a lead...
The session is centered around the tracing of systems on cloud using technologies like ebpf. The goal is to talk about what this technology is all about and what purpose it serves. In his session at 21st Cloud Expo, Shashank Jain, Development Architect at SAP, will touch upon concepts of observability in the cloud and also some of the challenges we have. Generally most cloud-based monitoring tools capture details at a very granular level. To troubleshoot problems this might not be good enough.
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
SYS-CON Events announced today that CAST Software will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CAST was founded more than 25 years ago to make the invisible visible. Built around the idea that even the best analytics on the market still leave blind spots for technical teams looking to deliver better software and prevent outages, CAST provides the software intelligence that matter ...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japanese Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Ruby Development Inc. builds new services in short period of time and provides a continuous support of those services based on Ruby on Rails. For more information, please visit https://github.com/RubyDevInc.
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
As businesses evolve, they need technology that is simple to help them succeed today and flexible enough to help them build for tomorrow. Chrome is fit for the workplace of the future — providing a secure, consistent user experience across a range of devices that can be used anywhere. In her session at 21st Cloud Expo, Vidya Nagarajan, a Senior Product Manager at Google, will take a look at various options as to how ChromeOS can be leveraged to interact with people on the devices, and formats th...
First generation hyperconverged solutions have taken the data center by storm, rapidly proliferating in pockets everywhere to provide further consolidation of floor space and workloads. These first generation solutions are not without challenges, however. In his session at 21st Cloud Expo, Wes Talbert, a Principal Architect and results-driven enterprise sales leader at NetApp, will discuss how the HCI solution of tomorrow will integrate with the public cloud to deliver a quality hybrid cloud e...
SYS-CON Events announced today that Yuasa System will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Yuasa System is introducing a multi-purpose endurance testing system for flexible displays, OLED devices, flexible substrates, flat cables, and films in smartphones, wearables, automobiles, and healthcare.
Is advanced scheduling in Kubernetes achievable? Yes, however, how do you properly accommodate every real-life scenario that a Kubernetes user might encounter? How do you leverage advanced scheduling techniques to shape and describe each scenario in easy-to-use rules and configurations? In his session at @DevOpsSummit at 21st Cloud Expo, Oleg Chunikhin, CTO at Kublr, will answer these questions and demonstrate techniques for implementing advanced scheduling. For example, using spot instances ...
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
SYS-CON Events announced today that Taica will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Taica manufacturers Alpha-GEL brand silicone components and materials, which maintain outstanding performance over a wide temperature range -40C to +200C. For more information, visit http://www.taica.co.jp/english/.